Company Fleury S.A.

Equities

FLRY3

BRFLRYACNOR5

Healthcare Facilities & Services

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Ratings for Fleury S.A.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical & Diagnostic Laboratories

Delayed Sao Paulo Other stock markets 04:07:37 2024-04-19 pm EDT			5-day change	1st Jan Change
14.04 ^BRL	-5.79%		-4.62%	-22.17%

Mar. 08	Transcript : Fleury S.A., Q4 2023 Earnings Call, Mar 08, 2024
Mar. 07	Fleury S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Fleury S.A. specializes in clinical diagnosis, treatment and analysis services.

At the end of 2018, the group operated a network of 187 patient care centers and 23 hospital centers under Fleury, Weinmann, Clínica Felipe Mattoso, a +, Labs a + and Diagnoson a + brands.

Number of employees: 27,300

BRL in Million	2022	Weight	2023	Weight	Delta
Diagnostic Medicine 70.4 %	3,505	78.5 %	4,555	70.4 %	+29.96%
Integrated Medicine 29.6 %	958	21.5 %	1,916	29.6 %	+99.93%

BRL in Million	2022	Weight	2023	Weight	Delta
Brazil 100.0 %	4,463	100.0 %	6,471	100.0 %	+44.99%

Managers	Title	Age	Since
Jeane Mike Tsutsui CEO	Chief Executive Officer	54	00-12-31
José Antônio de Almeida Filippo DFI	Director of Finance/CFO	63	21-07-22
Edgar Gil Rizzatti CTO	Chief Tech/Sci/R&D Officer	48	06-12-31
Fernando Aguiar SEC	Corporate Secretary	-	-
Claudio Almeida Prado PRN	Corporate Officer/Principal	60	15-12-31

Members of the board	Title	Age	Since
Luiz Carlos Trabuco Cappi BRD	Director/Board Member	72	-
Samuel Monteiro dos Santos BRD	Director/Board Member	78	13-04-08
João Teixeira BRD	Director/Board Member	57	21-04-29
Fernando Lopes Alberto BRD	Director/Board Member	55	16-12-31
Ivan Luiz Gontijo BRD	Director/Board Member	65	21-04-29
Marcio Pinheiro Mendes CHM	Chairman	50	14-12-31
Rui Monteiro de Barros Maciel BRD	Director/Board Member	78	78-12-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	547,191,026	240,604,046 ( 43.97 %)	2,150,089 ( 0.3929 %)	43.97 %

Name	Equities	%	Valuation
BANCO BRADESCO S.A. 24.85 %	135,958,586	24.85 %	407 M R$
Regina Pardini 6.613 %	36,187,918	6.613 %	108 M R$
Victor Cavalcanti Pardini 6.604 %	36,138,617	6.604 %	108 M R$
Áurea Pardini 6.583 %	36,021,540	6.583 %	108 M R$
Rui Monteiro de Barros Maciel 1.288 %	7,049,247	1.288 %	21 M R$
Bram Bradesco Asset Management S/A DTVM 1.236 %	6,761,027	1.236 %	20 M R$
Maria Lúcia Cardoso Gomes Ferraz 1.072 %	5,864,371	1.072 %	18 M R$
Granato Celso Francisco Hernandes 0.8998 %	4,923,630	0.8998 %	15 M R$
Marcio Pinheiro Mendes 0.7238 %	3,960,542	0.7238 %	12 M R$
Fundação dos Economiários Federais FUNCEF 0.6764 %	3,701,130	0.6764 %	11 M R$

Name	Equities	%	Valuation
FLEURY S.A. 0.07%	384,975	0.07%	1,153,643 $

Fleury SA

Avenida Morumbi 8860 – 8º andar

04703-003, SÃ£o Paulo

http://www.fleury.com.br

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

13.87 BRL

Average target price

19.8 BRL

Spread / Average Target

+42.75%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Providers & Services

Healthcare Facilities & Services

Medical & Diagnostic Laboratories

	1st Jan change	Capi.
FLEURY S.A.	-23.12%	1.44B
SONIC HEALTHCARE LIMITED	-18.11%	8.02B
RADNET, INC.	+36.93%	3.51B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-26.72%	2.97B
SYNLAB AG	-8.06%	2.48B
DR. LAL PATHLABS LIMITED	-14.11%	2.23B
NEOGENOMICS, INC.	-14.89%	1.76B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-39.19%	1.25B
ADICON HOLDINGS LIMITED	-11.20%	1.11B
METROPOLIS HEALTHCARE LIMITED	+3.67%	1.07B

Medical & Diagnostic Laboratories